Bulgaria Pharmaceuticals and Healthcare Report Q2 2012

Business Monitor International
March 6, 2012
89 Pages - SKU: BMI3805176
Executive Summary
SWOT Analysis
Bulgaria Pharmaceuticals And Healthcare SWOT
Bulgaria Political SWOT
Bulgaria Economic SWOT
Bulgaria Business Environment SWOT
Pharmaceutical Risk/Reward Ratings
Table: Central And Eastern Europe Pharmaceuticals Risk/Reward Ratings, Q212
Rewards
Risks
Bulgaria – Market Summary
Regulatory Regime
Pharmaceutical Advertising
Recent Regulatory Regime Developments
Intellectual Property Environment
Trademark Disputes
Pricing Regime
Pricing Regime Developments
Reimbursement Regime
Reimbursement Regime Developments
Industry Developments
Epidemiology
Table: Main Causes Of Death In Bulgaria (per 100,000 population)
Healthcare Sector
Healthcare Sector Developments
Healthcare Financing
Table: National Health Insurance Fund Budget
Research And Development
Clinical Trials
Medical Devices
Table: Classification Of Medical Devices In The EU
Industry Forecast Scenario
Overall Market Forecast
Table: Pharmaceutical Sales, 2008-2016
Key Growth Factors – Industry
Table: Overall Healthcare Expenditure, 2008-2016
Table: Government Healthcare Expenditure, 2008-2016
Table: Private Healthcare Expenditure, 2008-2016
Macroeconomic Forecast Scenario
Table: Bulgaria Economic Activity, 2011-2016
Prescription Drug Market Forecast
Table: Prescription Drug Sales, 2008-2016
Patented Drug Market Forecast
Table: Patented Drug Sales, 2008-2016
Generic Drug Market Forecast
Table: Generic Drug Sales, 2008-2016
OTC Medicine Market Forecast
Table: OTC Medicine Sales, 2008-2016
Table: OTC Medicines Breakdown, 2006-2010 (US$mn)
Medical Device Market Forecast
Table: Medical Devices Sales, 2008-2016
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade, 2008-2016
Other Healthcare Data Forecasts
Key Risks To BMI’s Forecast Scenario
Competitive Landscape
Pharmaceutical Industry
Local Pharmaceutical Sector
Foreign Pharmaceutical Sector
Foreign Company Activities
Wholesale Sector
Table: Pharmaceutical Wholesale And Retail Market in Bulgaria
Retail Sector
Company Monitor
Local Companies
Sopharma
Biovet
Actavis Bulgaria
Multinational Companies
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Merck & Co
Country Snapshot: Bulgaria Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education, 2002-2005
Table: Vital Statistics, 2005-2030
Section 3: Labour Market And Spending Power
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2000-2012 (US$)
Table: Average Annual Wages, 2000-2012
Glossary
BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Risk/Reward Ratings Methodology
Ratings Overview
Table: Pharmaceutical Risk/Reward Indicators
Weighting
Table: Weighting Of Components
Sources
 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,175  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!